CA
KNSA icon

CoreCap Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

CoreCap Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$345K Buy
+4,620
New +$340K 0.01% 663

Other funds holding KNSA

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors's KNSA Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 4,620 shares worth $345K. The stake represents 0.01% of the portfolio and ranks #663 among its holdings.

8 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • CoreCap Advisors held 4,620 shares of Kiniksa Pharmaceuticals worth $345K as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new CoreCap Advisors position in Q3 2026.
  • Kiniksa Pharmaceuticals made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #663 holding.
  • 8 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.